Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Lunit Unveils AI-Based Mammography Solution at RSNA 2018

By HospiMedica International staff writers
Posted on 26 Nov 2018
Lunit (Seoul, South Korea), a medical artificial intelligence (AI) software company, showcased its newest AI solution for breast cancer—Lunit INSIGHT for Mammography— at this year's gathering of Radiological Society North America (RSNA), which was held on November 25-30 at McCormick Place in Chicago, Ill., USA.

Lunit, abbreviated from "learning unit," is focused on developing advanced medical image analytics and data-driven imaging biomarkers via cutting-edge deep learning technology. More...
The company’s mission is to empower physicians with clinically actionable insights that foster accurate and cost-efficient diagnosis and treatment through unprecedented AI-powered imaging biomarkers with cutting-edge, world-leading accuracy.

Lunit's newest AI software, Lunit INSIGHT for Mammography delivers an accuracy of 97% in detecting malignant lesions, which is expected to increase the cancer detection rate of radiologists by 10% when used as a second reader. The company also claims that its AI solution can enable general radiologists to perform at a specialist level, providing solutions to health facilities that experience strains with lack of specialists. It also aims to decrease recall rate and as a result, save medical costs that are being wasted every year.

At RSNA 2018, the company also showcased Lunit INSIGHT for Chest Radiography, which has been tested in more than 1.5 million cases from more than 70 countries since being launched during last year's RSNA. With an accuracy level of 97-99%, it detects major chest abnormalities including nodules, consolidation, pneumothorax, etc. The CAD-based solution is also being integrated into the worklist for prioritization, in which positive cases may be read first in order to decrease turnaround time and increase overall reading productivity.

Lunit's proprietary AI technology has been trained with vast quality medical data to ensure high accuracy levels. The company’s AI has been trained with over 200,000 chest X-ray cases and 200,000 mammogram cases, out of which 50,000 cases were biopsy-proven malignant cases.

Lunit also presented six abstracts during RSNA 2018, consisting mainly of its latest findings and studies based on its AI technology in medical imaging such as mammography and chest radiography. Lunit’s new CEO Brandon Suh was on stage at Machine Learning Theater to give a presentation titled, “From AI-powered Diagnostic Support Tools to Imaging Biomarkers: Aiming Beyond Human-Level Accuracy,” which provided an overview of the company’s recent achievements and future developments.

Related Links:
Lunit

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Xenon Light Source
CLV-S400
Digital X-Ray Detector Panel
Acuity G4
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.